Department of Translational Medicine
21 – 30 of 9210
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Implementation of Recovery Tracker : A Postdischarge Electronic Remote Symptom-Monitoring Survey Tool After Major Urologic Oncology Surgeries
- Contribution to journal › Article
-
Mark
Comprehensive Analysis of the First 35 Years of Pediatric Heart Transplantation in Sweden
- Contribution to journal › Article
-
Mark
Risk of upper urinary tract urothelial carcinoma after primary non-muscle-invasive urinary bladder cancer : A nationwide population-based cohort study
- Contribution to journal › Article
-
Mark
Urine Glycosaminoglycan Scores for Surveillance of Recurrence in Intermediate- and High-risk Nonmetastatic Clear Cell Renal Cell Carcinoma-An Observational Prospective Multicentre Diagnostic Test Cohort Study
- Contribution to journal › Article
-
Mark
Thyroid peroxidase antibodies and their role in predicting outcomes in Graves’ disease treatment
- Contribution to journal › Article
-
Mark
Thrombotic risk determined by CREB3L1 variants in a population-based cohort study : linkage disequilibrium with prothrombin mutation
- Contribution to journal › Letter
-
Mark
LUND-PROBE – LUND Prostate Radiotherapy Open Benchmarking and Evaluation dataset
- Contribution to journal › Article
-
Mark
Validation of a Digital Pathology–Based Multimodal Artificial Intelligence Biomarker in a Prospective, Real-World Prostate Cancer Cohort Treated with Prostatectomy
- Contribution to journal › Article
-
Mark
Identification of cystatin C as a new marker of glomerular filtration rate, and of shrunken pore syndrome – a new kidney disorder defining selective glomerular hypofiltration syndromes – calls for expansion of the international KDIGO guidelines
- Contribution to journal › Scientific review
-
Mark
Screening performance and characteristics of breast cancer detected in the Mammography Screening with Artificial Intelligence trial (MASAI) : a randomised, controlled, parallel-group, non-inferiority, single-blinded, screening accuracy study
- Contribution to journal › Article
